These kits are used for qualitative detection of nucleic acids of Mpox Virus in blood and rash exudate from individuals who are suspected of having contracted Mpox Virus by their healthcare provider. They are indicated for use as aids in the diagnosis and monitoring of Mpox Virus infection.

According to the principles of fluorescence PCR technology, these kits are designed with specific primers and Taqman probes for Mpox Virus, and detect the nucleic acid of Mpox Virus through fluorescence PCR detector. These kits are equipped with an internal reference control to monitor sample collection, preservation and transportation, as well as nucleic acid extraction, to avoid false negative results.

These RT-PCR Mpox virus detection kits are CE-marked for sale in Europe and also authorized by the Medicines and Healthcare products Regulatory Agency (MHRA) the product regulatory agency for the UK. These tests perform with a sensitivity of 96.7% and specificity of 93.72%, with the ability to deliver results in under 70 minutes.